PharmaResearch Co., Ltd. (KOSDAQ:214450)

PharmaResearch Revenue

PharmaResearch had revenue of 146.10B KRW in the quarter ending March 31, 2026, with 24.97% growth. This brings the company's revenue in the last twelve months to 565.48B, up 44.14% year-over-year. In the year 2025, PharmaResearch had annual revenue of 536.29B with 53.18% growth.

• Revenue (ttm): 565.48B
• Revenue Growth: +44.14%
• P/S Ratio: 5.42
• Revenue / Employee: 1.04B
• Employees: 497
• Market Cap: 3.06T

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	536.29B	186.17B	53.18%
Dec 31, 2024	350.12B	89.10B	34.14%
Dec 31, 2023	261.01B	66.25B	34.02%
Dec 31, 2022	194.76B	40.68B	26.40%
Dec 31, 2021	154.08B	45.34B	41.69%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 14, 2026

Data Sources Report a data error